Both **Semaglutide** (found in Ozempic and Wegovy) and **Tirzepatide** (found in Mounjaro and Zepbound) are part of a new generation of medications known as **GLP1 receptor agonists**, designed to help with blood sugar control and weight loss.

While they may sound similar, there is actually a key difference in how they work.

**Semaglutide** mimics one hormone, **GLP1 (glucagon-like peptide-1)**, which helps your body regulate appetite, slow digestion, and manage blood sugar levels.

**Tirzepatide** works on two hormones, **GLP1** and **GIP (glucose-dependent insulinotropic polypeptide)**. This dual action can lead to greater appetite control, improved insulin sensitivity, and often faster weight loss results compared to Semaglutide.

**In short**

Semaglutide works with GLP1 only

Tirzepatide works with GLP1 and GIP, targeting two pathways instead of one

**Other differences to know**

Many Tirzepatide users report quicker and more noticeable weight loss, although side effects like nausea can be stronger at first.

Semaglutide tends to have a gentler start for some people, with slightly fewer stomach-related issues.

Dosing schedules are usually once a week, though titration and maximum doses vary between the two medications.

Everyone’s body responds differently, and what works best for one person may not work the same for another.

💬 Have you tried one or both? What differences did you notice in results or side effects?

**\*Please note that this is not medical advice but for educational purposes. Please always consult your medical practitioner before making your choice\***

Semaglutide vs Tirzepatide – What’s the Difference?